-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Transcode Therapeutics, Inc. quarterly/annual Interest Expense history and change rate from Q2 2020 to Q1 2025.
- Transcode Therapeutics, Inc. Interest Expense for the quarter ending 31 Mar 2025 was $114.000, a 98.8% decline year-over-year.
- Transcode Therapeutics, Inc. Interest Expense for the twelve months ending 31 Mar 2025 was $17.2K, a 67% decline year-over-year.
- Transcode Therapeutics, Inc. annual Interest Expense for 2024 was $26.8K, a 52% decline from 2023.
- Transcode Therapeutics, Inc. annual Interest Expense for 2023 was $55.9K, a 74.8% increase from 2022.
- Transcode Therapeutics, Inc. annual Interest Expense for 2022 was $32K, a 66.4% decline from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)